These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 519736)

  • 41. Bone resorption by osteoclasts.
    Teitelbaum SL
    Science; 2000 Sep; 289(5484):1504-8. PubMed ID: 10968780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Titanium particles stimulate bone resorption by inducing differentiation of murine osteoclasts.
    Bi Y; Van De Motter RR; Ragab AA; Goldberg VM; Anderson JM; Greenfield EM
    J Bone Joint Surg Am; 2001 Apr; 83(4):501-8. PubMed ID: 11315778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone.
    Carron CP; Meyer DM; Engleman VW; Rico JG; Ruminski PG; Ornberg RL; Westlin WF; Nickols GA
    J Endocrinol; 2000 Jun; 165(3):587-98. PubMed ID: 10828842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of CX3CL1/fractalkine in osteoclast differentiation and bone resorption.
    Koizumi K; Saitoh Y; Minami T; Takeno N; Tsuneyama K; Miyahara T; Nakayama T; Sakurai H; Takano Y; Nishimura M; Imai T; Yoshie O; Saiki I
    J Immunol; 2009 Dec; 183(12):7825-31. PubMed ID: 19923448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent advances in osteoclast biology and pathological bone resorption.
    Blair HC; Athanasou NA
    Histol Histopathol; 2004 Jan; 19(1):189-99. PubMed ID: 14702187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study.
    Taylor JC; Cuff SE; Leger JP; Morra A; Anderson GI
    Int J Oral Maxillofac Implants; 2002; 17(3):321-30. PubMed ID: 12074446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel ipriflavone receptors coupled to calcium influx regulate osteoclast differentiation and function.
    Miyauchi A; Notoya K; Taketomi S; Takagi Y; Fujii Y; Jinnai K; Takahashi K; Chihara K; Fujita T
    Endocrinology; 1996 Aug; 137(8):3544-50. PubMed ID: 8754785
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha.
    Tani-Ishii N; Tsunoda A; Teranaka T; Umemoto T
    J Dent Res; 1999 Oct; 78(10):1617-23. PubMed ID: 10520966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of CD44 deficiency on in vitro and in vivo osteoclast formation.
    de Vries TJ; Schoenmaker T; Beertsen W; van der Neut R; Everts V
    J Cell Biochem; 2005 Apr; 94(5):954-66. PubMed ID: 15578568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Observations on the ultrastructure of sinusoids and reticular cells in human bone marrow.
    Wickramasinghe SN
    Clin Lab Haematol; 1991; 13(3):263-78. PubMed ID: 1794229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis.
    Frith JC; Mönkkönen J; Auriola S; Mönkkönen H; Rogers MJ
    Arthritis Rheum; 2001 Sep; 44(9):2201-10. PubMed ID: 11592386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts.
    Perez-Amodio S; Beertsen W; Everts V
    J Bone Miner Res; 2004 Oct; 19(10):1722-31. PubMed ID: 15355568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation.
    Koyama H; Nakade O; Takada Y; Kaku T; Lau KH
    J Bone Miner Res; 2002 Jul; 17(7):1219-29. PubMed ID: 12096835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The giant cells recruited by subcutaneous implants of mineralized bone particles and slices in rabbits are not osteoclasts.
    Marks SC; Chambers TJ
    J Bone Miner Res; 1991 Apr; 6(4):395-400. PubMed ID: 1830447
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dissociation of angiogenesis and osteoclastogenesis during endochondral bone formation in neonatal mice.
    Deckers MM; Van Beek ER; Van Der Pluijm G; Wetterwald A; Van Der Wee-Pals L; Cecchini MG; Papapoulos SE; Löwik CW
    J Bone Miner Res; 2002 Jun; 17(6):998-1007. PubMed ID: 12054176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Localization of endothelin-1 in the osteoclast.
    Sasaki T; Hong MH
    J Electron Microsc (Tokyo); 1993 Jun; 42(3):193-6. PubMed ID: 8376925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
    Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts.
    Nakagawa M; Kaneda T; Arakawa T; Morita S; Sato T; Yomada T; Hanada K; Kumegawa M; Hakeda Y
    FEBS Lett; 2000 May; 473(2):161-4. PubMed ID: 10812066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An electron microscopic observation on cells found in bone resorption area incident to experimental tooth movement.
    Kurihara S
    Bull Tokyo Med Dent Univ; 1977 Mar; 24(1):103-23. PubMed ID: 265770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of cell-matrix interactions in osteoclast differentiation.
    McHugh KP; Shen Z; Crotti TN; Flannery MR; Fajardo R; Bierbaum BE; Goldring SR
    Adv Exp Med Biol; 2007; 602():107-11. PubMed ID: 17966395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.